These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 35012711

  • 1. The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study.
    Stone J, Artenie A, Hickman M, Martin NK, Degenhardt L, Fraser H, Vickerman P.
    Lancet Public Health; 2022 Feb; 7(2):e136-e145. PubMed ID: 35012711
    [Abstract] [Full Text] [Related]

  • 2. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.
    Trickey A, Fraser H, Lim AG, Peacock A, Colledge S, Walker JG, Leung J, Grebely J, Larney S, Martin NK, Hickman M, Degenhardt L, May MT, Vickerman P.
    Lancet Gastroenterol Hepatol; 2019 Jun; 4(6):435-444. PubMed ID: 30981685
    [Abstract] [Full Text] [Related]

  • 3. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, Walker JG, Ward Z, Stone J, Vickerman P, Homelessness, HIV, and HCV Review Collaborative Group.
    Lancet Public Health; 2021 May; 6(5):e309-e323. PubMed ID: 33780656
    [Abstract] [Full Text] [Related]

  • 4. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, Lynskey M, Griffiths P, Mattick RP, Hickman M, Larney S.
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [Abstract] [Full Text] [Related]

  • 5. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
    Hajarizadeh B, Kairouz A, Ottaviano S, Ireland J, Willing A, Cunningham E, Webb P, Colledge-Frisby S, Wheeler A, Leung J, Tran LT, Price O, Vickerman P, Farrell M, Hickman M, Dore GJ, Bergenström A, Degenhardt L, Grebely J.
    Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, Willing A, Kairouz A, Cunningham EB, Hajarizadeh B, Leung J, Tran LT, Price O, Peacock A, Vickerman P, Farrell M, Dore GJ, Hickman M, Grebely J.
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [Abstract] [Full Text] [Related]

  • 7. Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco.
    Fraser H, Stone J, Facente SN, Artenie A, Patel S, Wilson EC, McFarland W, Page K, Vickerman P, Morris MD.
    Int J Drug Policy; 2024 Sep; 131():104452. PubMed ID: 38910096
    [Abstract] [Full Text] [Related]

  • 8. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
    Stone J, Martin NK, Hickman M, Hutchinson SJ, Aspinall E, Taylor A, Munro A, Dunleavy K, Peters E, Bramley P, Hayes PC, Goldberg DJ, Vickerman P.
    Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL.
    Lancet Infect Dis; 2018 Feb; 18(2):215-224. PubMed ID: 29153265
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
    Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, McNaughton AL, Trickey A, Ward Z, Abramovitz D, Alary M, Astemborski J, Bruneau J, Clipman SJ, Coffin CS, Croxford S, DeBeck K, Emanuel E, Hayashi K, Hermez JG, Low-Beer D, Luhmann N, Macphail G, Maher L, Palmateer NE, Patel EU, Sacks-Davis R, Van Den Boom W, van Santen DK, Walker JG, Hickman M, Vickerman P, HIV and HCV Incidence Review Collaborative Group.
    Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):533-552. PubMed ID: 36996853
    [Abstract] [Full Text] [Related]

  • 14. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
    Leung J, Peacock A, Colledge S, Grebely J, Cunningham EB, Hickman M, Vickerman P, Stone J, Trickey A, Dumchev K, Lynskey M, Hines L, Griffiths P, Mattick RP, Degenhardt L, Larney S.
    J Infect Dis; 2019 Jun 05; 220(1):78-90. PubMed ID: 30726973
    [Abstract] [Full Text] [Related]

  • 15. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?
    Perlman DC, Des Jarlais DC, Feelemyer J.
    J Addict Dis; 2015 Jun 05; 34(2-3):198-205. PubMed ID: 26075647
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y, Larney S, Peacock A, Colledge S, Grebely J, Hickman M, Degenhardt L, Leung J.
    Int J Drug Policy; 2019 Aug 05; 70():87-93. PubMed ID: 31125802
    [Abstract] [Full Text] [Related]

  • 17. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
    Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H, Vos T.
    Lancet Infect Dis; 2016 Dec 05; 16(12):1385-1398. PubMed ID: 27665254
    [Abstract] [Full Text] [Related]

  • 18. Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review.
    Colledge S, Leung J, Grebely J, Degenhardt L, Peacock A, Hickman M, Vickerman P, Stone J, Trickey A, Larney S.
    Drug Alcohol Depend; 2020 Apr 01; 209():107899. PubMed ID: 32086179
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM, Gholami J, Sangchooli A, Rostam-Abadi Y, Olamazadeh S, Ardeshir M, Baheshmat S, Shadloo B, Taj M, Saeed K, Rahimi-Movaghar A.
    Lancet Glob Health; 2023 Aug 01; 11(8):e1225-e1237. PubMed ID: 37474230
    [Abstract] [Full Text] [Related]

  • 20. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
    Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, Grebely J, Dumchev KV, Griffiths P, Hines L, Cunningham EB, Mattick RP, Lynskey M, Marsden J, Strang J, Degenhardt L.
    Lancet Glob Health; 2017 Dec 01; 5(12):e1208-e1220. PubMed ID: 29074410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.